Replies to post #297922 on Avid Bioservices Inc (CDMO)

[revenue_monster]

distract and divert. it's everyone else's fault not leaderships.

[biopharm]

Collaborations are all about timing and deal structure ....I suppose you know that hardly anyone knows the financial details pending....and there are many other financial details surrounding Peregrine that may come as a surprise next week.

Two years is about up... All those biomarkers may now come in handy

May 29, 2015
Peregrine, Memorial Sloan Kettering Launch Cancer Collaboration

Peregrine Pharmaceuticals said today it will explore cancer-fighting treatments that combine its phosphatidylserine (PS)-targeting agents—including its lead drug candidate, the Phase III immuno-oncology prospect bavituximab for lung cancer—with other checkpoint inhibitors or immune stimulating agents, through a research collaboration with Memorial Sloan Kettering Cancer Center (MSK).

The value of the collaboration was not disclosed.
...
..
http://www.genengnews.com/gen-news-highlights/peregrine-memorial-sloan-kettering-launch-cancer-collaboration/81251330